769-19-7

Basic information

• Product Name: 4-BROMO-BENZOTHIAZOL-5-YLAMINE
• Synonyms: 5-AMINO-4-BROMO-BENZOTHIAZOLE;4-BROMO-BENZOTHIAZOL-5-YLAMINE;4-Bromo-1,3-benzothiazol-5-ylamine;5-Amino-4-bromo-1,3-benzothiazole;5-Benzothiazolamine, 4-bromo-;4-broMo-1,3-benzothiazol-5-aMine;4-BroMobenzo[d]thiazol-5-aMine
• CAS NO: 769-19-7
• Molecular Formula: C7H5BrN2S
• Molecular Weight: 229.1
• Mol File: 769-19-7.mol
• Article Data: 3

Chemical Properties

• Melting Point: 115 °C
• Boiling Point: 359.3 °C at 760 mmHg
• Flash Point: 171.1 °C
• Appearance: /
• Density: 1.836 g/cm³
• Vapor Pressure: 2.4E-05mmHg at 25°C
• Refractive Index: 1.783
• Storage Temp.: Keep in dark place,Inert atmosphere,Room temperature
• PKA: 0.50±0.10(Predicted)
• CAS DataBase Reference: 4-BROMO-BENZOTHIAZOL-5-YLAMINE(CAS DataBase Reference)
• NIST Chemistry Reference: 4-BROMO-BENZOTHIAZOL-5-YLAMINE(769-19-7)
• EPA Substance Registry System: 4-BROMO-BENZOTHIAZOL-5-YLAMINE(769-19-7)

Safety Data

• Hazard Codes: T
• Statements: 25
• Safety Statements: 45
• Hazardous Substances Data: 769-19-7(Hazardous Substances Data)

Usage

General Description

4-Bromo-benzothiazol-5-ylamine is a chemical compound with the molecular formula C7H5BrN2S. It is a brominated benzothiazole derivative, which is a class of compounds that are commonly used in the pharmaceutical industry as building blocks for various drugs and biologically active molecules. This particular compound has potential applications in the synthesis of pharmaceuticals and agrochemicals, and may also have uses in chemical research and development. Its structure and properties make it a versatile reagent for the development of new compounds with potential medicinal and agricultural applications.

InChI:InChI=1/C7H5BrN2S/c8-6-4(9)1-2-5-7(6)10-3-11-5/h1-3H,9H2

Upstream product

• 1123-93-9 5-aminobenzothiazole 
• 1336-21-6 ammonium hydroxide 
• 2942-07-6 5-nitrobenzothiazole 

Downstream Products

• 700-48-1 4,6-Dibrombenzothiazol 

Relevant articles and documents

ESTROGEN RECEPTOR MODULATORS AND USES THEREOF

Described herein are compounds that are estrogen receptor modulators. Also described are pharmaceutical compositions and medicaments that include the compounds described herein, as well as methods of using such estrogen receptor modulators, alone and in combination with other compounds, for treating diseases or conditions that are mediated or dependent upon estrogen receptors.

Guanidinyl heterocycle compounds useful as alpha-2 adrenoceptor agonists

This invention involves compounds having the following structure: as described in the Claims; and enantiomers, optical isomers, stereoisomers, diastereomers, tautomers, addition salts, biohydrolyzable amides and esters thereof, as well as pharmaceutical compositions comprising such novel compounds. The invention also relates to the use of such compounds for preventing or treating disorders modulated by alpha-2 adrenoceptors.